Central Standards Control Organization News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVAXIN approval a giant leap for innovation: Bharat Biotech CMD Krishna Ella January 03, 2021 Krishna Ella, MD, Bharat Biotech× The approval of COVAXIN for emergency use is a giant leap for innovation and novel product development in India, Krishna Ella, Chairman and Managing Director of Bharat Biotech, said. Expressing delight on the DCGI-Central Standards Control Organization grant of permission for emergency use of its Covid-19 vaccine, the CMD of vaccine maker said, "It is a proud moment for the nation and a great milestone in India's scientific capability. While this vaccine addresses ...

Updated Jan 03, 2021 | 13:41 IST Covaxin is a highly purified and inactivated 2 dose SARS-CoV2 vaccine, manufactured in a Vero cell manufacturing platform with an excellent safety track record of more than 300 million doses. Representational Image  Hyderabad: Expressing delight on the Ministry of Health & Family Welfare announcement and the statement from DCGI - Central Standards Control Organization (CDSCO) Grant of permission for emergency use of its Covid-19 Vaccine today, the Chairman and Managing Director of Bharat Biotech Dr Krishna Ella said “The appr...